REGISTER FOR OUR WEBINAR Gene Editing: Overhyped Or Unstoppable Tide?
Wednesday 14th June, 3pm GMT | 10am EST
Despite the initial hype surrounding gene editing, doubts persist about its potential to become a mainstream therapeutic approach. While Crispr/Cas9 gene editing made waves over a decade ago, only now is the first product using this technology nearing approval.
Gene Editing: Overhyped Or Unstoppable Tide?
Wednesday 14th June, 3pm GMT | 10am EST
In response, companies are exploring new in vivo approaches to gene editing that aim to make the process easier and less expensive. But with lingering doubts about the feasibility of these techniques, the future of gene editing remains uncertain.

Join our upcoming webinar for an in-depth discussion on the state of gene editing, including:

HIGHLIGHTS:

  • Will gene editing ever enter the mainstream?
  • The latest gene editing technology and trends in the market
  • The regulators' stance on gene editing
  • The latest deal making activity and the reality of investment in gene editing companies
Evaluate Ltd registered in England and Wales

Registered Address:
3 More London Riverside, London SE1 2AQ
Terms and conditions Privacy Policy Cookie Policy
Copyright 2023. Evaluate Ltd.